Astitva Foundation: Green Cards, Safer Generations – A Grassroots Fight Against Sickle Cell in Maharashtra
MUMBAI, India, May 11, 2026 /PRNewswire/ -- As Maharashtra celebrated its foundation…
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large…
Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: Arbor Biotechnologies Inc - Oral…
Herbalife India and IIT Madras Sign a Landmark Agreement to Establish India’s First Centre of Excellence on Plant Cell Fermentation
BANGALORE, India, April 16, 2026 /PRNewswire/ -- Herbalife International India Private Limited…
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
April 13, 2026 09:00 ET | Source: Senti Biosciences, Inc. SOUTH SAN…
ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems
Offering a new, validated CCS design pathway, reducing uncertainty for cautious battery…
NYUCT Design Labs launches Edible Ventures, a first-of-its-kind, full stack design and development cell for food & restaurant brands
MUMBAI, India, March 19, 2026 /PRNewswire/ -- NYUCT Design Labs, India's first…
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing ServicesBELTSVILLE, Md.,…
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader…
